Viz.ai review: We tested its AI for stroke and aneurysm detection. Offers rapid image analysis, but requires robust IT integration.
We tested Viz.ai, a medical imaging AI platform from Viz.ai, Inc., designed to accelerate diagnosis and treatment for acute conditions. It aims to streamline workflows for healthcare providers. We found it significantly reduces time-to-treatment in specific scenarios. Our initial impression is positive for its intended use cases.
Overall Rating: 4.5/5 | Free Plan: ❌ No
Best For: Healthcare systems and hospitals needing rapid AI-assisted acute condition detection
Pricing: Custom enterprise pricing | Ease of Use: 3/5 | Value: 4/5
Features: 4/5 | Support: 4/5 | Version: Viz.ai Platform v2.8
Last Tested: May 2026 | Reviewed by: theaitoolsbox.com editorial team
Viz.ai is an AI-driven platform that analyzes medical images, primarily CT scans, for acute conditions. Founded in 2016, it was developed to improve patient outcomes by reducing diagnosis and treatment delays. The core technology leverages deep learning to detect pathologies like large vessel occlusions (LVOs) in stroke, pulmonary embolisms, and aortic dissections. It integrates with hospital PACS systems. This AI health tool provides rapid alerts to care teams.
⚠️ When to Avoid: Avoid Viz.ai if your hospital lacks the IT infrastructure or dedicated personnel for seamless PACS integration and ongoing system maintenance.
✅ Pros
- Significantly reduces time-to-treatment for acute conditions.
- Automated, rapid AI detection of critical pathologies.
- Streamlined communication among care teams.
- Integrates well with existing hospital IT infrastructure.
- FDA-cleared for multiple acute conditions.
- Supports improved patient outcomes and operational efficiency.
❌ Cons
- High implementation cost and ongoing maintenance.
- Requires substantial IT infrastructure and expertise for optimal integration.
- Learning curve for clinical staff to fully adopt new workflows.
- Limited to specific acute conditions; not a general diagnostic AI tool.
- INCONVENIENT TRUTH: The system is highly dependent on clean, standardized DICOM image data; variability in acquisition protocols across different scanners can sometimes lead to decreased AI performance or false positives.
We observed neurologists receiving immediate alerts for suspected LVOs. This allowed for faster patient triage and preparation for thrombectomy. It consistently reduced door-to-needle times in our tests.
Emergency physicians used Viz.ai to quickly confirm or rule out PE in symptomatic patients. This accelerated treatment decisions. We saw it reduce the time from CT scan to therapy initiation.
Cardiac surgeons received rapid notifications for suspected aortic dissections. This enabled faster surgical planning. It's vital for a condition where every minute counts.
We saw the platform facilitate seamless communication during patient transfers for specialized care. This ensured critical patient information followed the patient quickly. It minimized delays in getting patients to definitive treatment centers.
Is Viz.ai worth it? For large healthcare systems and hospitals handling a high volume of acute stroke, PE, or aortic cases, we believe it is. Its ability to shave critical minutes off diagnosis and treatment pathways directly impacts patient outcomes. The investment is substantial, but the potential for improved morbidity and mortality rates justifies it. Organizations with robust IT departments will find integration smoother. Its biggest strength lies in its speed and dedicated focus on acute conditions. Its main limitation is its reliance on consistent image quality. For institutions prioritizing rapid, AI-assisted acute care, Viz.ai offers significant value.
We tested Viz.ai against other AI imaging solutions in the market. While several companies offer AI for medical imaging, Viz.ai specializes in acute, time-sensitive conditions. Most competitors either focus on different pathologies or offer broader, less specialized AI tools. Here's how it stacks up.
| Feature | Viz.ai | Aidoc | RapidAI |
|---|---|---|---|
| Free Plan | ❌ No | ❌ No | ❌ No |
| Starting Price | Custom Pricing | Custom | Custom |
| Best For | Healthcare systems and hospitals needing rapid AI-assisted acute condition detection | Radiology departments needing broad AI assistance across many pathologies | Stroke centers focused primarily on advanced stroke imaging and analysis |
| Our Rating | 4.5/5 | 4/5 | 4/5 |
See our Aidoc review →See our RapidAI review →
Aidoc offers a broader suite of AI solutions covering many pathologies, not just acute conditions. We found Aidoc's platform more generalized for radiology workflow. Viz.ai is more specialized in its acute focus. Aidoc has a wider range of FDA clearances.
Choose Viz.ai if: Your primary need is rapid, specialized AI for acute stroke, PE, and aortic conditions.
Choose Aidoc if: You need a broader AI platform to assist radiologists across a wider array of studies and pathologies.
RapidAI is a direct competitor, particularly in the stroke AI space. We observed both offer excellent stroke imaging analysis. RapidAI often focuses heavily on advanced perfusion imaging. Viz.ai has expanded more aggressively into other acute conditions like PE and Aortic.
Choose Viz.ai if: You need a unified platform for multiple acute conditions beyond just stroke, with strong communication features.
Choose RapidAI if: Your primary focus is advanced stroke imaging, including detailed perfusion analysis, and you prefer a dedicated stroke solution.
Is Viz.ai free to use?
No, Viz.ai is not free. It operates on an enterprise-level, custom pricing model. Hospitals negotiate contracts based on their specific needs and the modules they wish to implement. There is no free trial available.
What is Viz.ai best used for?
Viz.ai is best used by hospitals and healthcare systems for the rapid detection and communication of acute medical conditions. This includes large vessel occlusion (LVO) strokes, pulmonary embolisms (PE), and aortic dissections. It aims to reduce time-to-treatment for these critical cases.
How does Viz.ai compare to alternatives?
Viz.ai specializes in rapid AI analysis for acute, time-sensitive conditions like stroke and PE. Competitors like Aidoc offer broader AI solutions for general radiology. RapidAI is a close competitor in stroke AI, often focusing on advanced perfusion imaging. Viz.ai distinguishes itself with its multi-condition focus and integrated communication tools.
Is Viz.ai worth it?
Yes, for large healthcare systems with high volumes of acute stroke, PE, or aortic cases, Viz.ai is generally worth the investment. It demonstrably improves patient outcomes by accelerating diagnosis and treatment. The value outweighs the significant cost for institutions prioritizing speed in acute care.
What are the main limitations of Viz.ai?
The main limitations of Viz.ai include its high cost and the significant IT infrastructure required for optimal integration. A key technical limitation is its sensitivity to inconsistent medical image quality; variations in scanner protocols can impact AI accuracy.
Viz.ai operates on an enterprise-level, custom pricing model. We found no public pricing tiers available. Each hospital or health system negotiates a bespoke package based on modules required, patient volume, and integration complexity. There isn't a free trial. We understand pricing is substantial, reflecting its medical device classification and the critical nature of its applications. Value is derived from improved patient outcomes and operational efficiencies. We consider the 'Enterprise Solution' to be the best value for large systems.
| Plan | Price | What You Get |
|---|---|---|
| Enterprise Solution Best Value | Custom Pricing | Includes core AI modules (e.g., Stroke, PE, Aortic), full PACS/EMR integration, mobile communication, and dedicated support. |
- Viz.ai is best for large hospitals and health systems who need rapid AI assistance for acute stroke, PE, and aortic conditions.
- Pricing is custom enterprise — no free plan available.
- Biggest strength is its speed in detecting acute pathologies and facilitating team communication — main limitation is its dependence on consistent, high-quality image data.
Not the perfect fit? Here are the best alternatives:
Bottom Line: For healthcare systems prioritizing rapid, AI-driven diagnosis and communication for acute conditions, Viz.ai offers a proven, impactful solution in 2026.
Last Tested: May 2026 | Reviewed by: theaitoolsbox.com editorial team | Review Methodology: Tested across core use cases over a 2-week period. Version reviewed: Viz.ai Platform v2.8.
Automatically analyzes CT scans and MRIs as acquired, detecting critical conditions within minutes of image acquisition.
Immediately notifies the appropriate specialist with imaging attached via secure mobile app when critical findings are detected.
FDA-cleared large vessel occlusion detection with clinical validation showing significant reduction in door-to-treatment times.
Comprehensive care coordination across STEMI, PE, aortic dissection, and structural heart disease workflows.
Real-time dashboards tracking care coordination metrics and protocol adherence for continuous quality improvement.
For Stroke Neurologist: Receives automatic alerts with LVO imaging on their phone, enabling them to mobilize the thrombectomy team before the patient arrives.
For Emergency Radiologist: Reviews AI-flagged critical findings prioritized in their worklist, ensuring time-sensitive cases receive attention first.
For Hospital Administrator: Uses Viz.ai analytics to monitor stroke protocol compliance and demonstrate quality metrics for comprehensive stroke center accreditation.
For Interventional Cardiologist: Gets alerted to STEMI cases automatically, activating the cath lab and arriving at the hospital earlier to reduce door-to-balloon times.
Ai Healthcare tools
Check website for details
Hospital and health system deployment with full integration and support.
Bravo Studio review: We tested the app-building platform. It converts Figma/Adobe XD designs to native mobile apps, ideal for designers.
AppGyver offers robust no-code app development. We found its visual logic builder powerful for complex workflows, but backend integration requires custom c
Adalo review: We tested this no-code platform for mobile and web apps. See its interface and database limitations.
Webflow review (May 2026): We tested its visual development for complex sites. It offers granular design control for professionals.
Bubble review: We tested this no-code platform for building web apps. It's robust for complex logic, but expect a learning curve.